Recent Finacing
Recent Raise
Oncternal Therapeutics is a clinical-stage oncology company developing therapies that target cancer-specific proteins, advancing anti-ROR1 antibody cirmtuzumab, ETS-family inhibitor TK216, and an ADC program.
Focus Areas
Total Raised
Funding round